1. Influence of FMO3 and CYP3A4 Polymorphisms on the Pharmacokinetics of Teneligliptin in Humans
   Jin-Woo Park et al, 2021, Frontiers in Pharmacology CrossRef
2. CYP3A5*3 and SLCO1B1 c.521T>C Polymorphisms Influence the Pharmacokinetics of Atorvastatin and 2-Hydroxy Atorvastatin
   Jin-Woo Park et al, 2022, Pharmaceutics CrossRef